Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Omnicell, Inc. (OMCL : NSDQ)
 
 • Company Description   
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.

Number of Employees: 3,670

 
 • Price / Volume Information   
Yesterday's Closing Price: $29.84 Daily Weekly Monthly
20 Day Moving Average: 430,580 shares
Shares Outstanding: 46.84 (millions)
Market Capitalization: $1,397.81 (millions)
Beta: 0.76
52 Week High: $55.75
52 Week Low: $22.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.74% -8.02%
12 Week -4.33% -18.28%
Year To Date -32.97% -37.22%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4220 NORTH FREEWAY
-
FORT WORTH,TX 76137
USA
ph: 877-415-9990
fax: 847-596-3402
ir@omnicell.com http://www.omnicell.com
 
 • General Corporate Information   
Officers
Randall A. Lipps - Chief Executive Officer; President and Chairman
Nchacha E. Etta - Executive Vice President & Chief Financial Officer
Joanne B. Bauer - Director
Edward P. Bousa - Director
Mary A. Garrett - Director

Peer Information
Omnicell, Inc. (HLIS)
Omnicell, Inc. (AZTA)
Omnicell, Inc. (APYI)
Omnicell, Inc. (RNVA)
Omnicell, Inc. (HMSY)
Omnicell, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 68213N109
SIC: 3571
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 46.84
Most Recent Split Date: (:1)
Beta: 0.76
Market Capitalization: $1,397.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.54 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 55.26
Trailing 12 Months: 24.66
PEG Ratio: -
Price Ratios
Price/Book: 1.11
Price/Cash Flow: 9.75
Price / Sales: 1.23
EPS Growth
vs. Year Ago Period: 157.14%
vs. Previous Quarter: -82.22%
Sales Growth
vs. Year Ago Period: 9.55%
vs. Previous Quarter: -12.13%
ROE
06/30/25 - -
03/31/25 - 4.60
12/31/24 - 3.82
ROA
06/30/25 - -
03/31/25 - 2.56
12/31/24 - 2.07
Current Ratio
06/30/25 - -
03/31/25 - 1.38
12/31/24 - 1.37
Quick Ratio
06/30/25 - -
03/31/25 - 1.23
12/31/24 - 1.22
Operating Margin
06/30/25 - -
03/31/25 - 5.00
12/31/24 - 4.18
Net Margin
06/30/25 - -
03/31/25 - 1.87
12/31/24 - 1.13
Pre-Tax Margin
06/30/25 - -
03/31/25 - 2.98
12/31/24 - 2.30
Book Value
06/30/25 - -
03/31/25 - 26.84
12/31/24 - 26.84
Inventory Turnover
06/30/25 - -
03/31/25 - 7.02
12/31/24 - 6.74
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.13
12/31/24 - 0.13
Debt-to-Capital
06/30/25 - -
03/31/25 - 11.71
12/31/24 - 11.80
 

Powered by Zacks Investment Research ©